Annual gross profit:
$2.27B+$386.52M(+20.48%)Summary
- As of today (April 16, 2025), BMRN annual gross profit is $2.27 billion, with the most recent change of +$386.52 million (+20.48%) on December 31, 2024.
- During the last 3 years, BMRN annual gross profit has risen by +$897.92 million (+65.27%).
- BMRN annual gross profit is now at all-time high.
Performance
BMRN Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$611.17M+$53.89M(+9.67%)Summary
- As of today (April 16, 2025), BMRN quarterly gross profit is $611.17 million, with the most recent change of +$53.89 million (+9.67%) on December 31, 2024.
- Over the past year, BMRN quarterly gross profit has increased by +$87.52 million (+16.71%).
- BMRN quarterly gross profit is now at all-time high.
Performance
BMRN quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$2.27B+$102.90M(+4.74%)Summary
- As of today (April 16, 2025), BMRN TTM gross profit is $2.27 billion, with the most recent change of +$102.90 million (+4.74%) on December 31, 2024.
- Over the past year, BMRN TTM gross profit has increased by +$323.81 million (+16.61%).
- BMRN TTM gross profit is now at all-time high.
Performance
BMRN TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
BMRN Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.5% | +16.7% | +16.6% |
| 3 y3 years | +65.3% | +16.7% | +16.6% |
| 5 y5 years | +69.1% | +70.5% | +59.7% |
BMRN Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +65.3% | at high | +57.1% | at high | +61.0% |
| 5 y | 5-year | at high | +70.2% | at high | +112.2% | at high | +73.4% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
BioMarin Pharmaceutical Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $2.27B(+20.5%) | $611.17M(+9.7%) | $2.27B(+4.7%) |
| Sep 2024 | - | $557.28M(-4.2%) | $2.17B(+5.0%) |
| Jun 2024 | - | $581.57M(+11.1%) | $2.07B(+6.0%) |
| Mar 2024 | - | $523.65M(+3.0%) | $1.95B(+3.3%) |
| Dec 2023 | $1.89B(+18.5%) | $508.28M(+12.1%) | $1.89B(+6.6%) |
| Sep 2023 | - | $453.29M(-2.4%) | $1.77B(+3.8%) |
| Jun 2023 | - | $464.66M(+0.8%) | $1.71B(+3.3%) |
| Mar 2023 | - | $460.94M(+17.9%) | $1.65B(+3.7%) |
| Dec 2022 | $1.59B(+15.8%) | $390.89M(+0.5%) | $1.59B(+4.0%) |
| Sep 2022 | - | $389.06M(-5.3%) | $1.53B(+5.8%) |
| Jun 2022 | - | $410.67M(+2.1%) | $1.45B(+2.6%) |
| Mar 2022 | - | $402.39M(+21.9%) | $1.41B(+2.7%) |
| Dec 2021 | $1.38B(+3.0%) | $330.06M(+8.1%) | $1.38B(+0.3%) |
| Sep 2021 | - | $305.20M(-18.5%) | $1.37B(+1.3%) |
| Jun 2021 | - | $374.63M(+2.4%) | $1.35B(+3.3%) |
| Mar 2021 | - | $365.86M(+12.2%) | $1.31B(-1.9%) |
| Dec 2020 | $1.34B(-0.6%) | $325.98M(+13.2%) | $1.34B(-2.4%) |
| Sep 2020 | - | $287.99M(-13.1%) | $1.37B(-5.3%) |
| Jun 2020 | - | $331.52M(-15.1%) | $1.44B(+1.5%) |
| Mar 2020 | - | $390.67M(+9.0%) | $1.42B(+5.9%) |
| Dec 2019 | $1.34B(+14.3%) | $358.54M(-1.5%) | $1.34B(+6.4%) |
| Sep 2019 | - | $364.15M(+17.3%) | $1.26B(+4.2%) |
| Jun 2019 | - | $310.33M(-0.4%) | $1.21B(+1.4%) |
| Mar 2019 | - | $311.56M(+12.0%) | $1.20B(+1.7%) |
| Dec 2018 | $1.18B(+9.7%) | $278.24M(-11.1%) | $1.18B(-0.3%) |
| Sep 2018 | - | $312.81M(+6.5%) | $1.18B(+3.3%) |
| Jun 2018 | - | $293.83M(+0.9%) | $1.14B(+2.9%) |
| Mar 2018 | - | $291.11M(+3.1%) | $1.11B(+3.5%) |
| Dec 2017 | $1.07B(+18.1%) | $282.31M(+2.8%) | $1.07B(+4.5%) |
| Sep 2017 | - | $274.67M(+5.2%) | $1.03B(+4.6%) |
| Jun 2017 | - | $261.14M(+2.9%) | $979.98M(+1.3%) |
| Mar 2017 | - | $253.74M(+7.5%) | $967.36M(+6.6%) |
| Dec 2016 | $907.23M(+23.0%) | $235.94M(+3.0%) | $907.23M(+6.6%) |
| Sep 2016 | - | $229.16M(-7.8%) | $851.18M(+6.9%) |
| Jun 2016 | - | $248.51M(+28.4%) | $796.02M(+4.8%) |
| Mar 2016 | - | $193.62M(+7.6%) | $759.58M(+2.9%) |
| Dec 2015 | $737.89M(+17.7%) | $179.89M(+3.4%) | $737.89M(-1.6%) |
| Sep 2015 | - | $174.00M(-18.0%) | $749.74M(+3.8%) |
| Jun 2015 | - | $212.07M(+23.4%) | $722.37M(+7.7%) |
| Mar 2015 | - | $171.92M(-10.3%) | $670.88M(+6.9%) |
| Dec 2014 | $627.02M(+36.3%) | $191.75M(+30.8%) | $627.69M(+11.0%) |
| Sep 2014 | - | $146.63M(-8.7%) | $565.54M(+7.2%) |
| Jun 2014 | - | $160.58M(+24.7%) | $527.74M(+9.6%) |
| Mar 2014 | - | $128.74M(-0.7%) | $481.40M(+4.6%) |
| Dec 2013 | $460.09M | $129.60M(+19.1%) | $460.09M(+5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | $108.82M(-4.7%) | $435.90M(+1.2%) |
| Jun 2013 | - | $114.24M(+6.3%) | $430.57M(+3.3%) |
| Mar 2013 | - | $107.43M(+1.9%) | $416.78M(+1.9%) |
| Dec 2012 | $408.89M(+14.4%) | $105.41M(+1.8%) | $408.89M(+4.9%) |
| Sep 2012 | - | $103.50M(+3.0%) | $389.81M(+3.3%) |
| Jun 2012 | - | $100.44M(+0.9%) | $377.30M(+2.5%) |
| Mar 2012 | - | $99.54M(+15.3%) | $368.22M(+3.0%) |
| Dec 2011 | $357.33M(+16.8%) | $86.33M(-5.1%) | $357.33M(+1.5%) |
| Sep 2011 | - | $90.98M(-0.4%) | $352.15M(+3.3%) |
| Jun 2011 | - | $91.37M(+3.1%) | $340.92M(+4.2%) |
| Mar 2011 | - | $88.66M(+9.3%) | $327.10M(+6.9%) |
| Dec 2010 | $305.98M(+18.3%) | $81.14M(+1.8%) | $305.98M(+3.7%) |
| Sep 2010 | - | $79.75M(+2.8%) | $295.19M(+4.9%) |
| Jun 2010 | - | $77.55M(+14.8%) | $281.28M(+5.5%) |
| Mar 2010 | - | $67.54M(-4.0%) | $266.67M(+3.1%) |
| Dec 2009 | $258.75M(+6.1%) | $70.35M(+6.9%) | $258.75M(-6.3%) |
| Sep 2009 | - | $65.84M(+4.6%) | $276.00M(+2.7%) |
| Jun 2009 | - | $62.94M(+5.6%) | $268.75M(+3.2%) |
| Mar 2009 | - | $59.62M(-32.0%) | $260.39M(+6.7%) |
| Dec 2008 | $243.98M(+136.4%) | $87.61M(+49.6%) | $243.98M(+24.5%) |
| Sep 2008 | - | $58.58M(+7.3%) | $196.00M(+24.1%) |
| Jun 2008 | - | $54.58M(+26.3%) | $157.97M(+23.7%) |
| Mar 2008 | - | $43.21M(+9.0%) | $127.71M(+23.7%) |
| Dec 2007 | $103.22M(+36.8%) | $39.63M(+92.9%) | $103.22M(+25.9%) |
| Sep 2007 | - | $20.55M(-15.5%) | $82.00M(-2.1%) |
| Jun 2007 | - | $24.33M(+29.9%) | $83.77M(+2.0%) |
| Mar 2007 | - | $18.72M(+1.7%) | $82.10M(+8.8%) |
| Dec 2006 | $75.47M(+227.6%) | $18.40M(-17.5%) | $75.47M(+15.7%) |
| Sep 2006 | - | $22.32M(-1.5%) | $65.21M(+29.6%) |
| Jun 2006 | - | $22.66M(+87.4%) | $50.31M(+63.4%) |
| Mar 2006 | - | $12.09M(+48.4%) | $30.80M(+33.7%) |
| Dec 2005 | $23.04M(+56.9%) | $8.15M(+9.9%) | $23.04M(-9.6%) |
| Sep 2005 | - | $7.42M(+135.5%) | $25.48M(+39.9%) |
| Jun 2005 | - | $3.15M(-27.3%) | $18.21M(-4.2%) |
| Mar 2005 | - | $4.33M(-59.1%) | $19.02M(+29.5%) |
| Dec 2004 | $14.69M(+673.1%) | $10.59M(+7154.8%) | $14.69M(+258.6%) |
| Sep 2004 | - | $146.00K(-96.3%) | $4.10M(+3.7%) |
| Jun 2004 | - | $3.95M(+14.1%) | $3.95M(+14.1%) |
| Sep 2001 | - | $3.46M(-23.4%) | $3.46M(-75.2%) |
| Sep 2000 | - | $4.52M(-2.1%) | $13.99M(+4.6%) |
| Jun 2000 | - | $4.62M(-4.8%) | $13.37M(+16.7%) |
| Mar 2000 | - | $4.85M(+24.4%) | $11.45M(+33.3%) |
| Sep 1999 | - | $3.90M(+44.4%) | $8.59M(+83.1%) |
| Jun 1999 | - | $2.70M(+35.6%) | $4.69M(+135.6%) |
| Mar 1999 | - | $1.99M | $1.99M |
| Dec 1998 | $1.90M | - | - |
FAQ
- What is BioMarin Pharmaceutical annual gross profit?
- What is the all time high annual gross profit for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual gross profit year-on-year change?
- What is BioMarin Pharmaceutical quarterly gross profit?
- What is the all time high quarterly gross profit for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly gross profit year-on-year change?
- What is BioMarin Pharmaceutical TTM gross profit?
- What is the all time high TTM gross profit for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical TTM gross profit year-on-year change?
What is BioMarin Pharmaceutical annual gross profit?
The current annual gross profit of BMRN is $2.27B
What is the all time high annual gross profit for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual gross profit is $2.27B
What is BioMarin Pharmaceutical annual gross profit year-on-year change?
Over the past year, BMRN annual gross profit has changed by +$386.52M (+20.48%)
What is BioMarin Pharmaceutical quarterly gross profit?
The current quarterly gross profit of BMRN is $611.17M
What is the all time high quarterly gross profit for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly gross profit is $611.17M
What is BioMarin Pharmaceutical quarterly gross profit year-on-year change?
Over the past year, BMRN quarterly gross profit has changed by +$87.52M (+16.71%)
What is BioMarin Pharmaceutical TTM gross profit?
The current TTM gross profit of BMRN is $2.27B
What is the all time high TTM gross profit for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high TTM gross profit is $2.27B
What is BioMarin Pharmaceutical TTM gross profit year-on-year change?
Over the past year, BMRN TTM gross profit has changed by +$323.81M (+16.61%)